-
2
-
-
65349159791
-
Stage-specific outcomes of patients with uterine leiomyosarcoma: A comparison of the International federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems
-
Zivanovic O, Leitao MM, Iasonos A, Jacks LM, Zhou Q, Abu-Rustum NR, et al. Stage-specific outcomes of patients with uterine leiomyosarcoma: a comparison of the International federation of Gynecology and Obstetrics and American Joint Committee on Cancer Staging Systems. J Clin Oncol 2009;27:2066-72.
-
(2009)
J Clin Oncol
, vol.27
, pp. 2066-2072
-
-
Zivanovic, O.1
Leitao, M.M.2
Iasonos, A.3
Jacks, L.M.4
Zhou, Q.5
Abu-Rustum, N.R.6
-
3
-
-
0030220213
-
Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: A Gynecologic Oncology Group study
-
DOI 10.1006/gyno.1996.0220
-
Sutton G, Blessing JA, Malfetano JH. Ifosfamide and doxorubicin in the treatment of advanced leiomyosarcomas of the uterus: a Gynecologic Oncology Group Study. Gynecol Oncol 1996;62:226-9. (Pubitemid 26274804)
-
(1996)
Gynecologic Oncology
, vol.62
, Issue.2
, pp. 226-229
-
-
Sutton, G.1
Blessing, J.A.2
Malfetano, J.H.3
-
4
-
-
44449096592
-
Fixed-dose rate gemcitabine plus docetaxel as first-line therapy for metastatic uterine leiomyosarcoma: A Gynecologic Oncology Group phase II trial
-
DOI 10.1016/j.ygyno.2008.03.010, PII S0090825808002047
-
Hensley ML, Blessing JA, Mannel R, Rose PG. Fixed-dose rate gemcitabine plus doetaxel as first-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II trial. Gynecol Oncol 2008;109:329-34. (Pubitemid 351754961)
-
(2008)
Gynecologic Oncology
, vol.109
, Issue.3
, pp. 329-334
-
-
Hensley, M.L.1
Blessing, J.A.2
Mannel, R.3
Rose, P.G.4
-
5
-
-
67349224121
-
Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgica paradigm
-
Chi DS, Eisenhauer EL, Zivanovic O, Sonoda Y, Abu-Rusutm NR, Levine DA, et al. Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgica paradigm. Gynecol Oncol 2009;114:26-31.
-
(2009)
Gynecol Oncol
, vol.114
, pp. 26-31
-
-
Chi, D.S.1
Eisenhauer, E.L.2
Zivanovic, O.3
Sonoda, Y.4
Abu-Rusutm, N.R.5
Levine, D.A.6
-
6
-
-
80051550748
-
Surgical cytoreduction in stage IV endometrioid endometrial carcinoma
-
Shih KK, Yun E, Gardner GJ, Barakat RR, Leitao Jr MM. Surgical cytoreduction in stage IV endometrioid endometrial carcinoma. Gynecol Oncol 2011;122:608-11.
-
(2011)
Gynecol Oncol
, vol.122
, pp. 608-611
-
-
Shih, K.K.1
Yun, E.2
Gardner, G.J.3
Barakat, R.R.4
Leitao Jr., M.M.5
-
7
-
-
0036930778
-
Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma
-
DOI 10.1006/gyno.2002.6840
-
Leitao MM, Brennan MF, Hensley M, Sonoda Y, Hummer A, Bhaskaran D, et al. Surgical resection of pulmonary and extrapulmonary recurrences of uterine leiomyosarcoma. Gynecol Oncol 2002;87:287-94. (Pubitemid 36034649)
-
(2002)
Gynecologic Oncology
, vol.87
, Issue.3
, pp. 287-294
-
-
Leitao, M.M.1
Brennan, M.F.2
Hensley, M.3
Sonoda, Y.4
Hummer, A.5
Bhaskaran, D.6
Venkatraman, E.7
Alektiar, K.8
Barakat, R.R.9
-
8
-
-
34250186054
-
Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma
-
DOI 10.1016/j.ygyno.2007.02.031, PII S0090825807001801
-
Giuntoli II RL, Garett-Mayer E, Bristow RE, Gostout BS. Secondary cytoreduction in the management of recurrent uterine leiomyosarcoma. Gynecol Oncol 2007;106: 82-8. (Pubitemid 46901078)
-
(2007)
Gynecologic Oncology
, vol.106
, Issue.1
, pp. 82-88
-
-
Giuntoli II, R.L.1
Garrett-Mayer, E.2
Bristow, R.E.3
Gostout, B.S.4
-
9
-
-
41549166181
-
Uterine mesenchymal tumors: A review of selected topics
-
DOI 10.1016/j.mpdhp.2008.02.009, PII S1756231708000339
-
Soslow RA. Uterine mesenchymal tumors: a review of selected topics. Diagn Histopathol 2008;14:175-88. (Pubitemid 351470160)
-
(2008)
Diagnostic Histopathology
, vol.14
, Issue.4
, pp. 175-188
-
-
Soslow, R.A.1
-
11
-
-
78651372008
-
Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy
-
Munene G, Mack LA, Temple WJ. Systematic review on the efficacy of multimodal treatment of sarcomatosis with cytoreduction and intraperitoneal chemotherapy. Ann Surg Oncol 2011;18:207-13.
-
(2011)
Ann Surg Oncol
, vol.18
, pp. 207-213
-
-
Munene, G.1
Mack, L.A.2
Temple, W.J.3
-
12
-
-
0036498788
-
Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: A meta-analysis
-
DOI 10.1200/JCO.20.5.1248
-
Bristow RE, Tomacruz RS, Armstrong DK, Trimble EL, Montz FJ. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 2002;20:1248-59. (Pubitemid 34177431)
-
(2002)
Journal of Clinical Oncology
, vol.20
, Issue.5
, pp. 1248-1259
-
-
Bristow, R.E.1
Tomacruz, R.S.2
Armstrong, D.K.3
Trimble, E.L.4
Montz, F.J.5
|